• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 27-01-2026: Press Release

    27-01-2026 | 12:36 pm

    Alembic Pharma secured USFDA final approval for Difluprednate Ophthalmic Emulsion, 0.05%. This expands its US product portfolio, targeting ocular inflammation and pain, boosting future revenue potential.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited